The role of HPV testing in patients with possible high-grade cervical cytology

J Obstet Gynaecol Res. 2009 Jun;35(3):503-6. doi: 10.1111/j.1447-0756.2008.00944.x.

Abstract

Aim: To assess the role of human papillomavirus (HPV) testing for high-risk types in an Australian population with the equivalent cytological result of atypical squamous cells of undetermined significance - possible high-grade (ASC-H).

Methods: A retrospective review was conducted of all patients referred with a 'possible high-grade squamous abnormality' Pap-smear result who underwent HPV testing for 13 high-risk types, colposcopy and directed biopsy, and any subsequent treatment.

Results: The study included 100 patients. Overall, 79% of patients had a positive test for high-risk HPV DNA types. Histopathology was available for 98 patients and demonstrated that 47% of patients had confirmed high-grade dysplasia. HPV testing had a high sensitivity (98%), but low specificity (40%) for the detection of high grade dysplasia, and a negative predictive value of 95%.

Conclusions: The results of this study suggest that among patients with the equivalent of ASC-H cytology, a negative HPV DNA test for high-risk types is a good predictor of the absence of high-grade dysplasia. HPV testing in this patient population therefore has the potential to reduce the number women referred for colposcopy.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Australia
  • Cervix Uteri / pathology*
  • Cervix Uteri / virology*
  • Colposcopy
  • DNA, Viral / analysis*
  • Female
  • Humans
  • Middle Aged
  • Papanicolaou Test*
  • Papillomaviridae / genetics*
  • Sensitivity and Specificity
  • Uterine Cervical Dysplasia / pathology
  • Uterine Cervical Dysplasia / virology
  • Vaginal Smears*

Substances

  • DNA, Viral